Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients

Omalizumab Is Cost-Effective Compared To Standard of Care in Uncontrolled Severe Allergic Asthma Patients

Saved in:
Bibliographic Details
Published in:Value in health Vol. 21; p. S104
Main Authors: Kaur, H, Dongare, S, Lijie, W, Alvares, L
Format: Journal Article
Language:English
Published: 01-09-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-3015
DOI:10.1016/j.jval.2018.07.790